Checkpoint Therapeutics, Inc.
CKPTDelisted May 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651407
Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.
Holders of 5% or more of CKPT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Checkpoint Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Checkpoint Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Checkpoint Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202512:34 PM ET | Beryl Capital Management LLCand 3 others | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Jun 30, 2025 | SEC |
| Jun 3, 20256:46 PM ET | Fortress Biotech, Inc. | 13D/A | 0.00%0 shares | −11.20 ppfrom 11.20%Below 5% | May 30, 2025 | SEC |
| May 15, 20254:13 PM ET | Glazer Capital, LLCand 1 other | 13G/A | 3.81%3.17M shares | −2.60 ppfrom 6.41%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20253:34 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%4.36M shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Mar 17, 20255:04 PM ET | Beryl Capital Management LLCand 3 others | 13G | 9.90%6.07M shares | New | Mar 10, 2025 | SEC |
| Mar 17, 20254:08 PM ET | Glazer Capital, LLCand 1 other | 13G | 6.41%3.09M shares | New | Mar 10, 2025 | SEC |
| Mar 11, 20254:29 PM ET | Fortress Biotech, Inc. | 13D/A | 11.20%6.92M shares | −2.30 ppfrom 13.50% | Mar 9, 2025 | SEC |
| Feb 14, 20255:38 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%5.22M shares | – | Dec 31, 2024 | SEC |
| Jan 3, 20256:26 PM ET | Fortress Biotech, Inc. | 13D/A | 13.50%6.90M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Checkpoint Therapeutics, Inc. shares.
No Form 144 notices for Checkpoint Therapeutics, Inc. are on file.